These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23104430)

  • 1. Consideration of rat chronic progressive nephropathy in regulatory evaluations for carcinogenicity.
    Hard GC; Banton MI; Bretzlaff RS; Dekant W; Fowles JR; Mallett AK; McGregor DB; Roberts KM; Sielken RL; Valdez-Flores C; Cohen SM
    Toxicol Sci; 2013 Apr; 132(2):268-75. PubMed ID: 23104430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of advanced chronic progressive nephropathy (CPN) with renal tubule tumors and precursor hyperplasia in control F344 rats from two-year carcinogenicity studies.
    Hard GC; Betz LJ; Seely JC
    Toxicol Pathol; 2012 Apr; 40(3):473-81. PubMed ID: 22298794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of the renal effects of ethyl benzene in rodents for assessing human carcinogenic risk.
    Hard GC
    Toxicol Sci; 2002 Sep; 69(1):30-41. PubMed ID: 12215658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemically induced renal tubule tumors in the laboratory rat and mouse: review of the NCI/NTP database and categorization of renal carcinogens based on mechanistic information.
    Lock EA; Hard GC
    Crit Rev Toxicol; 2004; 34(3):211-99. PubMed ID: 15239388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemically exacerbated chronic progressive nephropathy not associated with renal tubular tumor induction in rats: an evaluation based on 60 carcinogenicity studies by the national toxicology program.
    Melnick RL; Burns KM; Ward JM; Huff J
    Toxicol Sci; 2012 Aug; 128(2):346-56. PubMed ID: 22539614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A contemporary overview of chronic progressive nephropathy in the laboratory rat, and its significance for human risk assessment.
    Hard GC; Khan KN
    Toxicol Pathol; 2004; 32(2):171-80. PubMed ID: 15200155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of rat chronic progressive nephropathy with human renal disease-implications for human risk assessment.
    Hard GC; Johnson KJ; Cohen SM
    Crit Rev Toxicol; 2009; 39(4):332-46. PubMed ID: 19514917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for the interpretation of renal tubule proliferative lesions occurring in rat kidneys with advanced chronic progressive nephropathy (CPN).
    Hard GC; Seely JC
    Toxicol Pathol; 2005; 33(6):641-9. PubMed ID: 16207638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathology re-examination of the NTP toxicity/carcinogenicity studies of tert-butyl alcohol to identify renal tumor and toxicity modes of action.
    Hard GC; Cohen SM; Ma J; Yu F; Arnold LL; Banton MI
    Regul Toxicol Pharmacol; 2019 Mar; 102():65-73. PubMed ID: 30590081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of hydroquinone-associated rat renal tumors with spontaneous chronic progressive nephropathy.
    Hard GC; Whysner J; English JC; Zang E; Williams GM
    Toxicol Pathol; 1997; 25(2):132-43. PubMed ID: 9125771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroquinone: an evaluation of the human risks from its carcinogenic and mutagenic properties.
    McGregor D
    Crit Rev Toxicol; 2007; 37(10):887-914. PubMed ID: 18027166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic progressive nephropathy in male F344 rats in 90-day toxicity studies: its occurrence and association with renal tubule tumors in subsequent 2-year bioassays.
    Travlos GS; Hard GC; Betz LJ; Kissling GE
    Toxicol Pathol; 2011 Feb; 39(2):381-9. PubMed ID: 21422264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological investigation of diagnostically challenging tubule profiles in advanced chronic progressive nephropathy (CPN) in the fischer 344 RaT.
    Hard GC; Seely JC
    Toxicol Pathol; 2006; 34(7):941-8. PubMed ID: 17178694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP technical report on the toxicology and carcinogenesis studies of beta-myrcene (CAS No. 123-35-3) in F344/N rats and B6C3F1 mice (Gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2010 Dec; (557):1-163. PubMed ID: 21415873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicology and Carcinogenesis Studies of Mercuric Chloride (CAS No. 7487-94-7) in F344 Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Feb; 408():1-260. PubMed ID: 12621522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-evaluation of the kidney tumors and renal histopathology occurring in a 2-year rat carcinogenicity bioassay of quercetin.
    Hard GC; Seely JC; Betz LJ; Hayashi SM
    Food Chem Toxicol; 2007 Apr; 45(4):600-8. PubMed ID: 17156907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of chronic progressive nephropathy on the incidence of renal tubule cell neoplasms in control male F344 rats.
    Seely JC; Haseman JK; Nyska A; Wolf DC; Everitt JI; Hailey JR
    Toxicol Pathol; 2002; 30(6):681-6. PubMed ID: 12512869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicology and Carcinogenesis Studies of C.I. Pigment Red 3 (CAS No. 2425-85-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1992 Mar; 407():1-289. PubMed ID: 12621523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.